Intra-Cellular Therapies Inc.

NASDAQ: ITCI · Real-Time Price · USD
131.87
0.00 (0.00%)
At close: Apr 01, 2025, 3:59 PM

Intra-Cellular Therapies Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
-74.68M-139.67M-256.26M-284.13M-227.01M-147.72M-155.13M-97.77M-116.43M
-8.52M528K656K533.36K528.12K477.12K368.67K213.87K196.87K
64.03M52.83M43.01M34.3M24.11M20.79M17.4M14.64M14.7M
-1.33M34.54M11.16M740.84K-7.53M5.95M12.16M-1.04M1.27M
82K-8.31M537K178.53K214.1K194.21K-529.97M1.06B233.77K
n/an/an/a-4.08M-648.25K-1.13M529.22M-1.06B544.35K
-54.1M-29.58M-58.14M-6.35M-27.28M-589.48K19.94M1.81M9.49M
-73.18M-124.2M-270.19M-259.54M-230.07M-127.98M-118.17M-80.49M-91.26M
-322K-269K-778K-325.74K-266.72K-700.39K-391.27K-723.43K-48.96K
n/an/a127.59M-280.67M480.03M-178.14Mn/an/an/a
-739.68M-415.27M-759.21M-224.57M-755.63M-80.72M-271.16M-520.93M-395.76M
404.85M521.08M631.61M505.24M275.6M258.86M406.19M428.93M488.07M
n/an/a-127.59M280.67M-480.03M178.14M135.03M-91.99M92.31M
-335.15M105.54M-128.37M280.34M-480.3M177.44M134.64M-92.72M92.26M
n/an/an/an/an/an/an/an/an/a
n/an/an/an/an/an/an/an/an/a
n/an/an/an/an/an/an/an/an/a
24.42M17.81M21.44M11.52M71.003.24M685.19K285.16K477.73K
567.51M17.81M455.16M11.52M664.18M3.24M685.19K162.36M477.73K
159.18M-848K56.6M32.32M-46.19M52.69M17.16M-10.85M1.48M
-73.5M-124.47M-270.96M-259.87M-230.34M-128.68M-118.56M-81.22M-91.31M